UBS (Lux) Equity Fund - Sustainable Health Transformation (USD), Anteilsklasse P-acc, USD
LU0085953304
UBS (Lux) Equity Fund - Sustainable Health Transformation (USD), Anteilsklasse P-acc, USD/ LU0085953304 /
NAV20/09/2024 |
Var.-3.5300 |
Type of yield |
Focus sugli investimenti |
Società d'investimento |
465.0700USD |
-0.75% |
reinvestment |
Equity
Worldwide
|
UBS Fund M. (LU) ▶ |
Investment strategy
The actively managed investment fund invests worldwide primarily in equities of companies related to the healthcare sector. This sub-fund promotes environmental and/or social features but does not pursue a sustainable investment objective. Based on thorough analyses by our investment specialists, the fund manager combines carefully selected stocks of different companies from different countries and different segments of the sector with the objective of taking advantage of interesting opportunities for returns while keeping risks under control. UBS Asset Management classifies this investment fund as a Sustainability Focus Fund, which promotes environmental and/or social characteristics.
The portfolio manager has discretion to construct the portfolio and is not bound by the benchmark in terms of equities and weightings. The investment fund is actively managed relative to the benchmark MSCI World Health Care (net div. reinv.). The investment fund uses the benchmark MSCI World Health Care (net div. reinv.) for portfolio composition, performance comparison and risk management.
Investment goal
The actively managed investment fund invests worldwide primarily in equities of companies related to the healthcare sector. This sub-fund promotes environmental and/or social features but does not pursue a sustainable investment objective. Based on thorough analyses by our investment specialists, the fund manager combines carefully selected stocks of different companies from different countries and different segments of the sector with the objective of taking advantage of interesting opportunities for returns while keeping risks under control. UBS Asset Management classifies this investment fund as a Sustainability Focus Fund, which promotes environmental and/or social characteristics.
Dati master
Type of yield: |
reinvestment |
Fondi Categoria: |
Equity |
Region: |
Worldwide |
Settore: |
Sector Health / Pharma |
Benchmark: |
MSCI World Health Care (net div. reinv.) |
Business year start: |
01/12 |
Ultima distribuzione: |
- |
Banca depositaria: |
UBS Europe SE, Luxembourg Branch |
Domicilio del fondo: |
Luxembourg |
Permesso di distribuzione: |
Austria, Germany, Switzerland, United Kingdom, Czech Republic |
Gestore del fondo: |
Matthew Konosky, Scott Wilkin, Caroline Wallace |
Volume del fondo: |
221.59 mill.
USD
|
Data di lancio: |
27/05/1998 |
Investment focus: |
- |
Condizioni
Sovrapprezzo emissione: |
5.00% |
Tassa amministrativa massima: |
1.37% |
Investimento minimo: |
- USD |
Deposit fees: |
- |
Redemption charge: |
0.00% |
Prospetto semplificato: |
Download (Print version) |
Società d'investimento
Funds company: |
UBS Fund M. (LU) |
Indirizzo: |
33A avenue J.F. Kennedy, 1855, Luxembourg |
Paese: |
Luxembourg |
Internet: |
www.ubs.com
|
Attività
Stocks |
|
98.68% |
Cash |
|
1.24% |
Altri |
|
0.08% |
Paesi
United States of America |
|
58.79% |
Switzerland |
|
14.32% |
United Kingdom |
|
9.32% |
Netherlands |
|
6.00% |
Japan |
|
4.62% |
Denmark |
|
2.14% |
China |
|
1.51% |
Cash |
|
1.24% |
Germany |
|
0.82% |
Virgin Islands (British) |
|
0.66% |
Ireland |
|
0.50% |
Altri |
|
0.08% |
Filiali
Pharma/Biotechnology |
|
50.82% |
Healthcare services |
|
27.90% |
Healthcare appliances |
|
16.53% |
grooming products |
|
1.56% |
Cash |
|
1.24% |
Gesundheitswesen/ Informationstechnologie |
|
1.09% |
Parma, wholesale |
|
0.79% |
Altri |
|
0.07% |